CLINICAL_TRIALS
trial_result
· 2014-03-06
Clinical Trial Update: Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants [Phase 4]
Summary
Phase 4 study assessing paliperidone extended-release for schizophrenia has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-03-06